Close Menu

NEW YORK -- OpGen announced after the close of the market on Tuesday an 8 percent revenue increase for the fourth quarter of 2019.

For the three months ended Dec. 31, 2019, OpGen's revenues grew to $821,674 from $758,959 million in Q4 2018. The company logged $570,674 in product revenue in Q4, and $250,000 in collaboration revenue.

Fourth quarter R&D expenses fell 42 percent to $1.1 million from $1.9 million, while SG&A costs dropped 19 percent to $1.7 million from $2.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.